MIRA INFORM REPORT

 

 

Report No. :

347419

Report Date :

31.10.2015

           

IDENTIFICATION DETAILS

 

Name :

GENIX - INDÚSTRIA FARMACÊUTICA LTDA

 

 

Registered Office :

Via Primária 1E - Quadra 3 - S/Nº. Módulos 1 E 2 Distrito Agroindustrial De Anápolis, 75133-660 - Anápolis/Go

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2014

 

 

Date of Incorporation :

28.03.2001

 

 

Legal Form :

Limited liability company

 

 

Line of Business :

Subject Is Engaged In The Manufacture And Sale Of Pharmaceutical Raw Materials

 

 

No. of Employees :

342

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

BRAZIL - ECONOMIC OVERVIEW

 

Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, and a rapidly expanding middle class, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. Since 2008, Brazil became a net external creditor and all three of the major ratings agencies awarded investment grade status to its debt.

After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. GDP growth has slowed since 2011, due to several factors, including: overdependence on exports of raw commodities, low productivity, high operational costs, persistently high inflation, and low levels of investment. After reaching historic lows of 4.5% in early 2014, the unemployment rate remains low, but is rising. Brazil's traditionally high level of income inequality has declined for each of the last 15 years.

Brazil’s fiscal and current account balances have eroded during the past four years as the government attempted to boost economic growth through targeted tax cuts for industry and incentives to spur household consumption. After winning reelection in October 2014 by a historically narrow margin, President Dilma ROUSSEFF appointed a new economic team led by Finance Minister Joaquim LEVY, who introduced a fiscal austerity package intended to restore the primary account surplus to 1.2% of GDP and preserve the country's investment-grade sovereign credit rating.

Brazil seeks to strengthen its workforce and its economy over the long run by imposing local content and technology transfer requirements on foreign businesses, by investing in education through social programs such as Bolsa Familia and the Brazil Science Mobility Program, and by investing in research in the areas of space, nanotechnology, healthcare, and energy.

 

Source : CIA

 

 

 

 


Company name

 

GENIX - INDÚSTRIA FARMACÊUTICA LTDA

 

 

ADDRESSES

 

MAIN ADDRESS:

VIA PRIMÁRIA 1E - QUADRA 3 - S/Nº. MÓDULOS 1 E 2 DISTRITO AGROINDUSTRIAL DE ANÁPOLIS

ZIP CODE/CITY:

75133-660 - ANÁPOLIS/GO

 

 

PHONE:

62 4010-9000

E-MAIL:

contabil@vrcontabil.cnt.br

WEB SITE:

www.genix.ind.br

 

BRANCHES:

 

 

 

ADDRESS:

RUA CORONEL CABRITA, 121 JARDIM DA GLÓRIA

ZIP CODE/CITY:

01545-030 SÃO PAULO/SP

PHONE:

11 2067-5600

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACTURE OF PHARMACEUTICALS.

 

LEGAL FORM:

LIMITED LIABILITY COMPANY

 

 

INCORPORATION DATE:

28/03/2001

REGISTER DATE:

03/04/2001

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

04.376.121/0001-93

STATE REGISTER:

10.338.210-0

 

 

SHARE CAPITAL:

R$ 35.000.000,00

LAST REGISTER OF CAPITAL:

01/11/2011

 

BOARD OF DIRECTORS:

 

 

 

JULIO TOMIZO TANAKA

MANAGING PARTNER

 

 

AUTHORIZED USE OF SIGNATURE:

 

THE MANAGING PARTNER IS AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

JULIO TOMIZO TANAKA

R$ 49.252.500,00

IVAN DA GLORIA TEIXEIRA

R$ 247.500,00

 

 

AFFILIATES / SUBSIDIARIES:

 

 

 

A SCAN THROUGH OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR DIRECTORS HAS/HAVE THE FOLLOWING UNCONFIRMED HOLDINGS:

 

 

J.V.T. CONSTRUTORA E INCORPORADORA LTDA

 

GEMINI INDUSTRIA DE INSUMOS FARMACEUTICOS LTDA

 

LVA PARTICIPAÇÕES LTDA

 

D CRIS CONFECÇÕES LTDA

 

PP LVA PARTICIPAÇÕES LTDA

 

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON MARCH 28, 2001 TO BE ENGAGED IN THE SAID LINE OF BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL SCENE REPORTED HEREIN.

 

TRADE NAME: "GENIX".

 

PARTNERS:

 

JULIO TOMIZO TANAKA: BRAZILIAN, MARRIED, ENTREPRENEUR, RESIDENTIAL ADDRESS AT RUA DAS PRIMAVERAS 255, CONDOMINIO BOUGUEVILLE III, ZIP CODE 11750-000, PERUÍBE/SP, HOLDER OF DOCUMENTS RG 11.005.913 SSP-SP AND CPF 006.297.068-24;

 

IVAN DA GLORIA TEIXEIRA: BRAZILIAN, MARRIED, ENTREPRENEUR, RESIDENTIAL ADDRESS AT RUA 3, Nº. 483, APTO 401, CONDOMINIO SOLAR DAS ACÁCIAS, SETOR OESTE, ZIP CODE 74115-050, GOIÂNIA/GO, HOLDER OF DOCUMENTS RG 405.390 SSP-GO AND CPF 160.156.571-20.

 

FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

NO DETRIMENTAL FILES WERE FOUND.

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2014, 31/12/2013 AND 31/12/2012.

( FIGURES ARE IN REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2014

31/12/2013

31/12/2012

 

 

 

 

CASH AND BANKS

4.403.166,76

4.385.275,68

648.481,07

SHORT TERM INVESTMENTS

 

 

15.606.100,14

CLIENTS

14.141.105,73

12.738.641,87

12.640.543,62

INVENTORY

8.660.570,06

6.337.139,26

8.971.641,85

ADVANCE TO EMPLOYEES

356,50

5.242,24

9.705,61

OTHER ADVANCES

27.560,89

970.160,83

42.969,24

ACCOUNTS RECEIVABLE

11.331.103,41

10.925.173,83

116.541,03

RECOVERABLE TAXES

2.224.258,73

2.897.069,12

2.573.288,39

PRE PAID EXPENSES

65.958,30

31.297,85

89.229,99

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

40.854.080,38

38.290.000,68

40.698.500,94

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

CREDITS

10.180.592,43

9.359.939,56

8.142.646,15

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

10.180.592,43

9.359.939,56

8.142.646,15

 

FIXED ASSETS:

 

 

 

 

 

 

 

FIXED ASSETS

20.794.675,32

17.956.267,61

18.347.177,57

INTANGIBLE

609.088,15

661.701,21

671.412,71

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

21.403.763,47

18.617.968,82

19.018.590,28

 

================

================

================

TOTAL ASSETS

72.438.436,28

66.267.909,06

67.859.737,37

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2014

31/12/2013

31/12/2012

 

 

 

 

SUPPLIERS

4.001.936,06

2.846.616,89

2.288.402,38

FOREIGN SUPPLIERS

 

 

1.863.548,91

SALARIES PAYABLE

447.293,02

387.795,19

281.372,86

SOCIAL OBLIGATIONS

457.185,52

390.627,46

395.700,05

PROVISIONS

525.185,80

532.214,46

1.056.056,22

TRIBUTARY OBLIGATIONS

800.587,62

995.489,43

687.464,82

ACCOUNTS PAYABLE

205.085,61

432.264,86

247.541,46

FREIGHTS PAYABLE

17.419,38

19.137,81

31.768,04

ADVANCE FROM CLIENTS

2.193,82

14.750,87

13.057,55

OTHER DEBTS

292.891,64

396.281,98

314.808,62

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

6.749.778,47

6.015.178,95

7.179.720,91

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

222.814,66

389.925,82

557.036,98

TRIBUTARY OBLIGATIONS

9.301.525,71

9.742.030,29

5.665.708,18

INSTALLMENTS TAXES PAYABLE

 

383.884,99

652.958,49

LEASING

 

11.824,57

7.417.310,95

GOODS FROM THIRD PARTIES

 

2.569.347,13

 

DEFERRED REVENUE

 

14.071,83

 

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

9.524.340,37

13.111.084,63

14.293.014,60

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

35.000.000,00

35.000.000,00

35.000.000,00

CAPITAL RESERVES

14.730.329,37

10.895.534,08

10.895.534,08

ACCRUED PROFIT (LOSS)

6.433.988,07

1.246.111,40

491.467,78

 

----------------

----------------

----------------

TOTAL NET EQUITY

56.164.317,44

47.141.645,48

46.387.001,86

 

================

================

================

TOTAL LIABILITIES

72.438.436,28

66.267.909,06

67.859.737,37

 

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2014, 31/12/2013 AND 31/12/2012.

( FIGURES ARE IN REAIS ).

 

 

31/12/2014

31/12/2013

31/12/2012

 

 

 

 

GROSS SALES

69.529.853,01

69.479.083,79

70.247.089,84

(-) TAXES ON SALES

10.676.488,92

14.415.552,60

13.110.028,71

 

----------------

----------------

----------------

NET SALES

58.853.364,09

55.063.531,19

57.137.061,13

(-) COST OF SOLD GOODS

39.868.636,89

39.470.074,22

43.195.473,82

 

----------------

----------------

----------------

GROSS PROFIT

18.984.727,20

15.593.456,97

13.941.587,31

OPERATING REVENUE (EXPENSE)

-8.374.680,32

-8.349.736,05

-12.175.972,97

FINANCIAL REVENUE(EXPENSE)

3.914.645,66

-86.117,76

5.120.402,14

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

14.524.692,54

7.157.603,16

6.886.016,48

NON-OPERATING RESULT

76.900,00

73.387,48

175.636,40

CONTRIBUTION/INCOME TAX

-2.312.497,00

-2.415.020,77

-706.941,25

 

----------------

----------------

----------------

NET PROFIT (LOSS)

12.289.095,54

4.815.969,87

6.354.711,63

 

 

MONTHLY SALES

 

  2015

 

 

 

---------------------

 

 

JANUARY

R$ 5.398.261,69

 

 

FEBRUARY

R$ 4.630.742,51

 

 

MARCH

R$ 5.803.408,14

 

 

APRIL

R$ 5.450.987,74

 

 

MAY

R$ 5.966.824,99

 

 

JUNE

R$ 5.447.314,14

 

 

JULY

R$ 5.183.763,43

 

 

AUGUST

R$ 5.711.685,13

 

 

SEPTEMBER

R$ 5.347.444,22

 

 

OCTOBER

 

 

 

NOVEMBER

 

 

 

DECEMBER

 

 

 

TOTAL

R$ 48.940.431,99

 

 

 

 

RATIOS:

31/12/2014                

31/12/2013

31/12/2012

 

QUICK RATIO

4,77

 

5,31

 

4,42

 

CURRENT RATIO

6,05

 

6,37

 

5,67

 

ACCOUNTS RECEIVABLE TURNOVER

4,16

TIMES

4,32

TIMES

4,52

TIMES

DAYS' SALES IN RECEIVABLES

86,50

DAYS

83,28

DAYS

79,64

DAYS

INVENTORY TURNOVER

4,60

TIMES

6,23

TIMES

4,81

TIMES

ACCOUNTS PAYABLE PERIOD

36,14

DAYS

25,96

DAYS

19,07

DAYS

RETURN ON ASSETS

,81

TIMES

,83

TIMES

,84

TIMES

SALES TURNOVER ON NET EQUITY

1,05

TIMES

1,17

TIMES

1,23

TIMES

NET WORTH TIE-UP

,37

 

,38

 

,40

 

INDEBTEDNESS

,29

 

,41

 

,46

 

EQUITY RATIO

77,53

%

71,14

%

68,36

%

WORKING CAPITAL RATIO

505,27

%

536,56

%

466,85

%

GENERAL SOLVENCY

4,45

 

3,46

 

3,16

 

RETURN ON NET EQUITY

21,88

%

10,22

%

13,70

%

RETURN ON SALES (PROFIT MARGIN)

20,88

%

8,75

%

11,12

%

GROSS PROFIT MARGIN

32,26

%

28,32

%

24,40

%

OPERATIONAL RESULT

24,68

%

13,00

%

12,05

%

SALES TURNOVER ON LIABILITIES

8,72

TIMES

9,15

TIMES

7,96

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 3,87

 - OFFICIAL RATE ON 28/10/2015

US$ 1,00 = R$ 2,65

 - OFFICIAL RATE ON 31/12/2014

US$ 1,00 = R$ 2,34

 - OFFICIAL RATE ON 31/12/2013

US$ 1,00 = R$ 2,04

 - OFFICIAL RATE ON 31/12/2012

 

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE ANNUAL FIGURES SHOW GOOD FINANCIAL STANDING. IT HAS HIGH LIQUIDITY RATIOS AND GOOD WORKING CAPITAL, AS WELL AS LOW LEVEL OF INDEBTEDNESS. IT SHOWS RECOVERY IN SALES AND POSTED PROFIT.

 

 

REAL ESTATE:

 

   OWNED PREMISES ARE VALUED AT R$ 13.799.341,90

 

VEHICLES:

 

OWNED VEHICLES ARE VALUED AT R$ 386.302,67

 

 

MACHINES:

 

OWNED MACHINES AND EQUIPMENTS ARE VALUED AT R$ 15.569.864,88

 

 

INSURANCE

 

NOT AVAILABLE.

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

 

BANCO SANTANDER (BRASIL) S/A

62 3311-2002

 

BANCO DO BRASIL S/A

62 3311-1633

 

BANCO ITAÚ S/A

62 3311-1893

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK"). DATE RESEARCHED OCTOBER 28, 2015.

 

 

ACTIVITIES COMMENTS

 

THE SUBJECT IS ENGAGED IN THE MANUFACTURE AND SALE OF PHARMACEUTICAL RAW MATERIALS.

 

IMPORT AND EXPORT:

 

   IMPORTS FROM:

COLOMBIA, CHINA, UNITED STATE, INDIA AND OTHERS.

 

   EXPORTS TO:

DOES NOT EXPORT.

 

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

CITY:

 

DROGADERMUS DROG. E FARM. DE MAIP. LTDA

GOIÂNIA/GO

 

FARMACIA IANNARELLI LTDA

JOÃO MOLEVADE/MG

 

MICROGRAMA FARM. MANIP. LIDA - ME

RIBEIRÃO PRETO/SP

 

RENATA BATAGLIA GALLI

JUNDIAÍ/SP

 

 

 

STAFF:

 

THE COMPANY HAS: 342 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 2001. SO FAR IT HAS A CLEAR TRADE HISTORY AND NORMAL PAYMENT BEHAVIOR.

 

THE COMPANY HAS TRADE RELATIONS WITH SOME SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

 

PHONE:

BIOQUÍMICA SUPRIMENTOS ANALÍTICOS LTDA

 

16 2138-6111

DEGUSA BRASIL LTDA

 

11 3146-4100

ELETRO RODNEY MATS. ELETRICOS LTDA

 

62 3311-6888

EMBALAGENS BANDEIRANTES LTDA

 

11 4061-1115

GELITA DO BRASIL S/A

 

11 4612-8111

LOCGUEL LOC. DE EUQUIPAMENTOS PARA CONSTRUÇÃO LTDA

 

31 3464-0166

MERCK S/A

 

11 3346-8500

PERKIN ELMER DO BRASIL LTDA

 

11 3868-6200

SINTEFINA IND E COM LTDA.

 

11 4056-7887

UNI TINTAS LTDA

 

62 3310-8600

WATERS TECHNOLOGIES DO BRASIL LTDA

 

11 4193-6133

 

 

FOREIGN SUPPLIERS:

COUNTRY:

 

CHIBA NATIONAL AERO-TECHOLOGY IMP & EXP. XIAME CORPORATION

CHINA

 

IPCA LABORATORIES LTDA

INDIA

 

SINOCHEM JIANGSU CORPORATION

CHINA

 

 

 

PAYMENT HISTORY:

 

04 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 23.064,00

 

AMOUNT OF INVOICES PAID: 11

TOTAL OF PROMPT PAYMENTS: 100%

HIGHEST INVOICE: R$ 4.609,00

HIGHEST CREDIT: R$ 11.130,00

 

 

 

FINAL OPINION

 

THE SUBJECT HAS BEEN IN BUSINESS SINCE 2001. UP TO DATE IT HAS CLEAR TRADE HISTORY AND NORMAL PAYMENT BEHAVIOR.

 

BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH.


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.65.22

UK Pound

1

Rs.99.93

Euro

1

Rs.71.67

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

TRU

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.